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Retroviral-mediated transfer 01 new genetic infor-
mation into keratinocytes is a key step in epidermal 
gene therapy. An obstacle to the use of retroviruses 
for gene therapy is that although high levels o f 
expression of the transduced gene can be maintained 
in tissue culture, expression is often lost when the 
cells are transplanted to an anhnal host. To examine 
some of the factors involved in this instability of 
expression, we transduced k e ratinocytes with a ret-
rovirus encoding the gene for human factor IX and 
T he ability to introduce new gen etic infonl1atioll in to ke ra tlnocytes h as proven to be a valu abl e research too l (Fe nj ves , 1994) and is a prereguisite for u sing keratinocytes as a vehicle for gen e therapy (Can-oU e/ aI, 1993). At th e present time , th e most e ffici ent 
method for gen e t ransfe r to ke ratin ocytes is with retr ovira l v ectors 
(M iller e/ aI, 1993) , but express ion o f tb e transdu ced gene is o ften 
lost, esp ecially w he n ex 11 ;1'" modifi e d cclls arc t ran spla nted to an 
anima l h ost (G e rrard el aI , 1993). Illstabi li ty of exp l'css io ll ill II iI/O 
co uld be attr ib u ted to difFe rent facto rs, s u c h as loss of transplanted 
cell s o r inhibition at the transc rip tiona l or tran slationa l level. In th e 
case of a secreted gene product, loss of exp ress ion could a lso result 
fi'om a 'b lock to the n ormal secret01'y path way. T h e presen t 
investigation was under taken to explore the loss of express ion of a 
transduced gen e in w hich th e gene product is n o rl11 a lly secreted. 
Keratinocytes were transduced w ith a retrov ira l vector e ncoding 
hum an cl otting facto r IX . Express io n o f t1us gen e was monitol-ed b y 
the presen ce of facto r IX in the m e dia of transduced kel:atinocytes 
in c lli ture and b y th e presen ce of factor IX in th e c irc ul ation of 
athYl1li c mice g rafte d w ith the sa me ke ra th:lOcytes. We d e mon strate 
th at th e transplan ted cell s survive and that p rod ucts secreted fro m 
these cell s do indeed reac h th e bl oodstream; however, fac to r IX 
express io n is dimini she d o r lost in cells grafted to a n animal h ost. 
MATEIUALS AND METHODS 
CeIJ Cul t ure and Retroviral Transduction Human newborn foreskin 
kerarinocytes were grown in submerged clll tllres (I<..hei" wa ld and G reen, 
1975) and fi rst passage ce ll s (5 X '105 ce ll s in a 60-lI1m dish) were transduced 
with L1 XSN retrovirus at a titer of5 X '105 CflJlml as previously described 
(Garlick el a i , 1991). UXSN is derived from Mo loney mouse Icukelll.ia virus 
and encodes the cDNA fo r human ulcto r IX under th e contro l of the 
retrovirus L T I<" and the bacteri al ge ll e for nconlyc in resistance (nco') under 
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nl0nitored secretion of t h e transduced gene. We 
observed continued secretion of factor IX through 
five passages in culture. When, however, sheets of 
these cells were grafted to athymic mice, factor IX 
expression was reduced or lost within 6 wk. We show 
that the reduction of factor IX expression in grafted 
keratinocytes did not result from a loss of grafted 
cells, nor was there a block to systemic delivery of a 
secreted endogenous product. KejI words: g elle thempy' 
facto" I X. ] Invest D el'tllato/ 106:576-578, 1996 
the contro l o f the SV40 proll1 ote r (Yao c{ nl, '199 1). U XSN retrovirus was 
prepared by transfecting vector DNA into cp-2 packaging cells (Danos alld 
Mu lligan, '1988) and jnfecti ng alllphotropic cp-C IUP packaging cells with 
medium fj'o m the transfected cell s. Tr:l ll sduccd kerntinocytes were selected 
by growth in G418 (600 mg/ml) fo r 14 d and expanded further withollt 
G418 selection. 
Animal Grafts Athymic mice were grafted as previously described 
(Fc llj ves e{ nl, 1989). Briefly, epithel ial sheets de ri ved fro 111 cOIIAuent 
cul tures were detached with Dispase II (G rcell cl nl, 1979). A petrolatum-
impregnated, nOllad herill g dress ing (Adaptic, J ohnson & J OhIlSOIl, Skillman, 
NJ) was placed 0 11 top of the epitheliulII as suppo rti ve backing. Allimals 
we re anestheti zed with Metofane gas. T he ep ithelia l sheet was grafted basal 
side down on a 2 X 1-cm graft bed excised to fascia on the backs of the 
rni ce. 
Factor IX Determination To fo llow express ion of the factor IX gelle in 
culture, keratinocytes we re p laced in mediulll conta in ing factor IX-de-
pIcted SerUIl1 and vitamin K (10 J.l.g / ll1l , Aq ua-mephyton, Merck, \Vest 
POill t, PAl. Enzyme-lin ked imlllunosorbent assay (Yao e { nl, 199'1) was used 
to assay tissue culture mcdia for f;,ctor IX as we ll as systcmic deli very of 
Glctor IX in Illi ce grafted with transduced cell s. 
Immunohistochemistry and ApoE Determination The presence of 
hU l11a n keratinocytes at graft sites was mo ni to red by imlllllllosta ini llg with 
an alltibody to hu man involucrin (Fe llj vcs cl " I, 1 99~) , and human apoli-
poprotcin E (a poE) in the seru m of grafted mice was detenn ined by 
cnzyme-linked immunosorbellt assay (Gordon ('{ nl, 1989). 
RESULTS 
Keratinocytes Transduced with LIXSN Secrete Factor IX 
First pass ke ratinocytes transduced w ith LlXSN w ere se lected with 
G418 and seed ed in to 10-cm culture di shes in cu lture medium 
d evo id of v itamin K . A t ime course of f.1cto r IX secretio n was 
es tab li sh ed b), Ill eas uring f.1ctor IX acclllllul ation in th e m edia and 
cO lln t in g the numbe r of cell s per dish over 5 d. Facto r IX 
accumula ted in the m e dium at the rate of393 ::t 64 ng/ :J 0" cell s/12 
h through th e logarithmi c and p lateau g ro wth of the ce ll s . Mock 
tran sduced cell s w e re include d as a con t ro l in thi s e xper iment and 
were shown to secrete no detectable facto r IX. 
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Figure 1. Continued expression of factor IX in LIXSN-transduced 
cells with passage. Keratinocytes trallSduced with UXSN and selected 
with G418 were passaged and f.1ctor IX was collected in se rum-free medium 
over an 8-h period. T he average va lli e from three plates is plotted; error bars, 
tbe range of va lues. 
Factor IX Expression is Stable in Culture To determine if 
expression of Glctor IX was stably mainta ined w ith cell passage, the 
cells were subcul tured and factor IX secretion assayed at each 
passage. Cell s w ere passaged by trypsinizin g and seeding at 1 X 105 
celis/100-mm dish thus mainta ining a minimum of 2 wk between 
passages. Factor IX secretion was measured when ce lls reached 
80 - 90'1'0 confluence. T h e results plotted in Fig 1 show there was no 
reduction of factor IX production during five consecutive passages 
in c ulture. T illS resul t indicates that in culture the transduced gen e 
is expressed for at least 10 wk. 
Factor IX Expression is not Stable in Grafted Keratinocytes 
T o gauge if factor IX expression contin ued in grafted cells, cultures 
of confluent transduced keratinocytes were grafted to fu ll-thickness 
excised sites on the backs of four athymic mice. Mice were bled by 
retro-orbita l puncture, and leve ls of factor IX in their serum were 
measured a t intervals (Fig 2). Ini tia ll y, the levels of f.1ctor IX were 
in the range of1.2- 2.7 ng/ml . With time however, se rum levels of 
facto r [)( decreased. In Mice 1 and 2, f.1cto r IX leve ls fe ll to 0.5 
ng/ml over a period of30-44 d . In Mouse 3, levels offacto r IX fe ll 
to zero withill 23 d. T hese resu lts show that there was a steady 
decrease in the level of f.1 ctor IX in th e seru m of mice g rafted w ith 
transduced cells. No factor IX could be detected in three mice 
grafted with mock-transduced keratinocytes w hen assayed on days 
9, 23, 30, and 44 post grafting (data not shown). 
To determine if facto r IX persisted in the serum , even after its 
production fi'om the graft stopped, the graft was excised fi'om a 
fo urth mOLlse (data not shown) at 40 d post grafting, when serum 
levels of factor IX were 0.5 ng/ml. Two days later (42 d post 
grafting), factor IX could not be detected in the blood . 
Grafted Human Keratinocytes Persisted throughout the 
Experiment To confirm that the grafts were indeed present at all 
tUnes during the course of this experiment, grafts were removed 
and exam ined histologicall y for the presence of human involucr in . 
As shown in Fig 3, the human cells were evident at 30 d post 
grafting. Furthermore, to verity that protein secreted by g rafted 
cells could reach the bloodstream, serum fi'om Mouse 3 taken 44 d 
post g rafting was analyzed for the presence of human apoE. ApoE 
is secreted by keratinocytes and is recovered in serum of rnice 
beari ng grafts of human keratinocytes (Fenj ves ct ai, 1989). T he 
presen ce of " poE in the serum of grafted animals is evidence that 
there is no barrier to systemic delivery . It also serves as a confir-
mation that human cell s are present in the g rafi: . At 44 d post 
grafting, no factor IX was present in the serum of Mouse 3. T here 
w as human apoE present at 1.0 ng/ ml , however, thus ruling o ut an 
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Figure 2. Systemic delivery of factor IX in three athymic mice 
grafted with human keratinocytes transduced with LIXSN. At 
variolls tiln es, b lood was obtained fi'0111 the rni ce and factor IX levels in the 
serum was measured by enzyme-linked il1lmllnosorbent assay (Yao <:I aI, 
1991). T he lower Ijmi t of factor IX detection was 0.35 ng/ml. Data are 
expressed as t he average of readings Oil tVlO independent enzynlc-li nked 
inllllU110sorbent assays: error !Jars, the range of values. 
obstacle to systemic de li very. Furthermore, as human apoE ha s a 
half-Li fc of1.5 h in athymic micc (Fenjves c/ ai, 1994). its continued 
prescnce 44 d post grafting co uld not have resulted [rom residual 
apoE rcmaining after production of the prote in had ceased . Another 
mouse grafted with mock-transdu ced cclls had 1.4 ng/ ml apoE in 
its serum . T h e reduction in factor IX Icvels in the serum of grafted 
mice probably resul ted fi~om a loss of expression of the transduced 
gene. 
DISCUSSION 
A reduction of expression of a genc transduced into n ormal 
keratin ocytes has been noted by others followin g transplantation to 
an an imal host . Flowers cf al (1990) transduced canine kcratinocytes 
with a rctrovira l vector that cncoded th e gene for neomycin 
res istance and graftcd nonselected cul tures a long with a colJagen-
fibrob last support to subcLltaneous sites in the donor animals. T he 
mean percentage of nco" keratinocytes in the nonselected cu ltures 
at the time of grafting w as 31 % (range: 0.3-80'1.,). At va rious times 
up to 30 d post grafting, grafts were rcm oved and keratin ocytes 
cultu red fro ll1 the tiss uc. T he mean percentage of nco ' cclls in these 
o utgrowths was 1 % (range: 0.1-3%) . A lthough long-term persis-
ten ce of nco" cells was demonstrated , w hether any of the cell s 
culturcd fi'0111 the grafts co nta ined the nco" gene but did not express 
the n eo" phenotype was not determin ed . Such cells would have 
verified loss of tnlllsgene e xpress ion, as suggested by the reduced 
percentage of nco" cell s cul tured fi'om the g rafts . In other experi-
ments , auto logous transplantation of canine kenltinocytes express-
ing /3-gal;1ctosidase showed loss of expression of th e transferred 
gene within 2 wk post g rafting (Stockschl ader <:/ ai, 1994). Finally, 
tactor IX was not detectable in the serul1l of nude mice g rafted with 
LlXSN transdu ced human keratin ocytes within a week of grafting 
(Gerrard <:1 al. 1993) . In th is instance the epithelial cells were 
cultured on a collagen matrix and grafted to subcutaneous sites in 
the mouse. For reasons tha t a rc unclear, culturing the cell s on a 
coll agen matrix was essential for secretion of hlctor IX into the 
cu lture med ium . 
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F igure 3 . Histological localization of huma n cells in grafted tissue. 
C ro ss section of a hll l1l ~111 kcrutil10cytc graft on ~111 :lth y l11ic 1l1 0 USC gr~ ftcd 
with kerntill ocytes transduced w ith L1XSN . Tissue fro 111 the graft si te was 
removed and processed fo r immul1osra il1ing w ith all antibody specific for 
hllll",n invo lucrin (as prev io usly desc ribed IFenj ves dil l . 1 '.I94J). wh.ich 
stai ns onl y human suprabasal kcratil1ocytcs. T h e tiss ue shown was taken 
fro nl Mouse 1 at 30 d . --+ , rh c jullc tio n between c p id c n Tli s of I lllIna 11 o ri g in 
(/<:li) and mo use epide rmis (r(~hl). Sfnl" 1mI'. 5 0 !Lm. 
Although loss of gen e express ion is the like ly explan ation for 
th ese resu lts . there are other poss ibil ities that Illu st be consid ere d . 
Subcutaneo ll s inj ection of puri fied hum an factor IX in mi ce shows 
rap id effi c ient transport in to the bloodstream of bio logica ll y active 
factor IX w ith a half- life c learan ce of unde r 20 h o urs (Ge rra rd 1'1 ai, 
1992). T his makes it improbab le that the o b served loss of detection 
is re lated to changes in meta bolism o f the facto r IX by th e mi ce. 
T he possibili ty that there ma y be inductio n o f a serum prote in that 
interfe res w ith the f;l cto r IX assay was add resse d by doing W estern 
blot anal ys is of recombin ant factor IX in plasma of mice (Yao el ai , 
1994) . 
Loss of expression has been noted in other cell types th at we re 
transdu ced ill "ifm and subsequ ently transplanted to suitable si tes in 
animals. T hese cell s include cutaneo us fi bro blasts (S charfilHlIHl ('1 al. 
1991), IH~ patocytes (S trauss, 1994), m yo blasts (Dai el ai, 1992), and 
hem atopo ietic cells (Kaleko ef ai , 1990) . T h e m echaniSI11 undedy-
ing loss of expressio n has not been well c h ara cteri zed, bu t jn t he 
few studi es w here the mechanism ha s b een examin ed . I11RNA fo r 
th e trans'duced gene has been absent (Palmer ('/ ai, 1991). In all of 
these in stances viral pro moters were use d to reg ul ate expression of 
the ne wl y in serted gene, lea ding to the suggestio n th'lt ill "i"o, viral 
pro moters are se lectiv e ly inactivated , possibly by meth ylation of 
specifi c bases in the pro moter (ChalLi ta and Kohn , 1994). In the 
study reported here, facto r IX was und er th e contl'ol of t he 
retrovi rall o ng te rminal repeat sequence . The use o f an endoge no us 
tissue-specifi c promoter has, in se veral in stances, been show n to 
pro long express io n or provide long- te rm expression , fu rthel' sup-
porting th e concept of se.l ective inactivation of vira l promote rs in 
grafted cell s (Nafr;lkh ef ai , 1995; H ea rtle in cf ai , 1994; Hafen ri chter 
cl ai , 1994; Dai cf ai , 1992). The mechanism of ina c tivatio n ofvinl 
promoters by transplantatio n is unknown but mu st be ca refully 
examined be fo re keratinocytes can be considered sui table target 
ce lls for gene therapy. 
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